|
Judith Ann Clements 〔(【引用サイトリンク】 publisher=Sydney Morning Herald )〕 is an Australian Professor who specialises in Kallikrein proteases in prostate and ovarian cancers. Clements is the Scientific Director at the Australian Prostate Cancer Research Centre – Queensland and was head of the Cancer Research Program at the Institute of Health and Biomedical Innovation (IHBI) of Queensland University of Technology at the Translational Research Institute (Australia) from 1997–2014. == Biography == Distinguished Professor Judith Clements is a Principal Research Fellow of the National Health and Medical Research Council (NHMRC) of Australia and lead the Cancer Program from 1997–2014 at the Institute of Health and Biomedical Innovation, QUT, based at the Translational Research Institute on the Princess Alexandra Hospital Biomedical Precinct. She is also Scientific Director of the Australian Prostate Cancer Research Centre-Queensland located on this campus. Her areas of expertise include prostate and ovarian cancer, with respect to the Kallikrein proteases and their utility as biomarkers and therapeutic targets for cancer progression. She has over 190 publications in scientific journals and collaborates widely with colleagues in the US, Canada, the UK and Europe. She is the Chair of the national prostate cancer tissue bank – the Australian Prostate Cancer BioResource, which is a key resource that underpins prostate cancer research nationally and is co-leader of the Queensland node of the international genome wide association study consortium for prostate cancer, PRACTICAL. She is Chair of the Queensland Board of the Prostate Cancer Foundation of Australia (PCFA) and a member of the PCFA National Board. She has been a member of the QIMR Berghofer Medical Research Institute Council since 2002. She was recently elected as a member of the International Proteolysis Society Council for 2014–2017. She was awarded the Queensland Women in Technology Biotech Outstanding Achievement Award for 2012, and the prestigious title of Distinguished Professor at QUT in 2013. Clements' research specialises in ovarian and prostate cancers, particularly focusing on the Kallikrein proteases and their utility as biomarkers and therapeutic targets for cancer progression. Clements has publications in over 190 publications scientific journals.〔(【引用サイトリンク】url=https://www.tri.edu.au/staff/judith-clements )〕〔(【引用サイトリンク】url=http://www.ncbi.nlm.nih.gov/pubmed?term=Clements%20JA )〕 Clements is currently organising the 2 International Meetings: the 6th annual International Symposium on Kallikreins and Kallikrein-Related Peptidases (ISK 2015), to be held in Brisbane, Australia from 28 September – 1 October 2015 and 9th General Meeting of the International Proteolysis Society, to be held in Penang, Malaysia from 4–5 October 2015. In June 2015 in the Queens Birthday Honors, Clements received an Companion of the Order of Australia (AC), awarded for eminent achievement and merit of the highest degree in service to Australia or to humanity at large. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Judith Clements」の詳細全文を読む スポンサード リンク
|